1. 1. 2018; PubMed.gov; Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?1. 2018; PubMed.gov; Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis? https://www.ncbi.nlm.nih.gov/pubmed/29308975s://www.ncbi.nlm.nih.gov/pubmed/29308975
14. 12. 2018; DMSG; ULTIPLE SKLEROSE.TV: RUMPFÜBUNGEN BEI MS https://www.dmsg.de/multiple-sklerose-news/dmsg-aktuell/multiple-sklerosetv-rumpfuebungen-bei-ms/ 14. 12. 2018; ms-uk; MS patients who are stable on interferon therapy show better outcomes than those who switch https://www.ms-uk.org/ms-patients-who-are-stable-interferon-therapy-show-better-outcomes-those-who-switch 13. 12. 2018; MSIF; Results Published from Australian HSCT Bone Marrow Stem Cell Transplantation Trial in MS https://www.nationalmssociety.org/About-the-Society/News/Results-Published-from-Australian-HSCT-Bone- Marrow?feed=AllNationalNews 13. 12. 2018; aerztezeitung.de; Von Fingolimod profitieren auch Kinder mit MS https://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/multiple_sklerose/article/976845/multiple- sklerose-fingolimod-profitieren-kinder-ms.html?wt_mc=nl.upd.AEZ_NL_NEWSLETTER.2018-12-13.Multiple+Sklerose.x 7. 12. 2018; DMSG; MEHR ALS JEDER ZEHNTE MULTIPLE SKLEROSE-ERKRANKTE IST VON AUGENBEWEGUNGSSTÖRUNGEN BETROFFEN https://www.dmsg.de/multiple-sklerose-news/ms-forschung/mehr-als-jeder-zehnte-multiple-sklerose-erkrankte-ist-von- augenbewegungsstoerungen-betroffen/ 7. 12. 2018; amsel.de; Was kann ich noch tun? https://www.amsel.de/multiple-sklerose-news/medizin/was-kann-ich-noch-tun/ 5. 12. 2018; ms-uk; Real world study tests the effects of weather and temperature on MS patients treated with Rebif https://www.ms-uk.org/real-world-study-tests-effects-weather-and-temperature-ms-patients-treated-rebif 5. 12. 2018: e-med forum; Pflanzenschutzmittel können Nerven schädigen http://www.emed-ms.de/index.php?id=533&tt_news=3075 4. 12. 2018; MSIF; FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada https://www.nationalmssociety.org/About-the-Society/News/FDA-Issues-Warning-About-Rare-Risk-of-Stroke-and- A?feed=AllNationalNews 4. 12. 2018; pubmed. gov; Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). https://www.ncbi.nlm.nih.gov/pubmed/30515631 4. 12. 2018; e-med forum; Schalter für die Regeneration von Nervenzell-Isolierschicht entdeckt http://www.emed-ms.de/index.php?id=533&backPID=433&tt_news=3078 4. 12. 2018; Ärzte Zeitung online,; Ozanimod - Neue MS-Arznei punktet in Phase III https://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/multiple_sklerose/article/977263/ozanimod- neue-ms-arznei-punktet-phase-iii.html?wt_mc=nl.upd.AEZ_NL_NEWSLETTER.2018-12-04.Multiple+Sklerose.x Novemer 2018 Oktober 2018 September 2018 August 2018 Juli 2018 Juni 2018 Mai 2018 April 2018 März 2018 Feb. 2018 Jan. 2018 Dez. 2017 Nov. 2017 Okt. 2017 Sept. 2017 August 2017 Juli 2017 Juni 2017 Mai 2017 April 2017 März 2017 Februar 2017 Jänner 2017 Dezember 2016 November 2016 Oktober 2016 September 2016 August 2016 Juli 2016 Juni 2016 http://www.dmsg.de/multiple-sklerose-news/ http://www.amsel.de/multiple-sklerose-news/8 http://www.emed-ms.de/News.news.0.html http://www.ms-life.de/mslife/ms-nachrichten/aktuelles/content-150952.html http://www.aktiv-mit-ms.de/ms-news/ http://www.leben-mit-ms.de/de/patientenundangehoerige/nachrichten/page.html http://www.msif.org/en/research/ms_research_news/index.html http://idw-online.de/pages/de/ticker http://www.pressemitteilungen-online.de/?s=multiple+sklerose http://www.nature.com/ http://www.thelancet.com/journals/lancet/issue/current http://www.neurology.org/ http://www.nejm.org/medical-index http://www.jneurosci.org/ http://www.clineu-journal.com/ http://www.ncbi.nlm.nih.gov/pubmed http://msj.sagepub.com/ http://www.ms-uk.org/MSnews/ Kennen Sie einen informativen MS-Link? Lassen Sie ihn mich bitte wissen! Ein Geschenk ist genau so viel wert wie die Liebe, mit der es ausgesucht worden ist. Thyde Monnier Zur Startseite
http://georgieff.at/
Herzlich willkommen auf georgieff.at,
Sie haben eine gute Wahl getroffen.
Das Lesen dieser Homepage ist gratis, aber nicht umsonst.
Hier erfahren Sie über Fakten, nicht von “Gschichtln”.
Wie auch immer -
kein Facebook, kein Twitter, kein Instagram,
so free
… Anm.:
Junge Menschen verbringen bis zu sieben Stunden täglich mit ihrem
Smartphone.  Aber bin ja nicht mehr jung…
Der Dalai Lma sagt; “Wenn man die Ruhe nicht in sich selbst findet, ist es
umsonst, sie anderswo zu suchen.”
Institut für Koreanische Handmassage IKHM
Die
Website für Koreanische Handmassage
Verein Weak MuSkle VWM
Die
aktuellste
Website für Multiple Sklerose
Sollten Sie sich fragen, ob diese Homepage von einer Firma betrieben wird, die ihre
Produkte bewirbt oder von einem selbst betroffenen Arzt, der seinem hippokratischen Eid
verpflichtet ist, lesen Sie einfach weiter.
Hier werden Sie nicht aufgefordert, mit
Therapietreue ein bestimmtes Medikament zu konsumieren, sondern Ihr Hirn
einzuschalten und das Heft selbst in die Hand zu nehmen.
Neue und wichtige Studien, Publikationen und Links zu MS - Stand 28. 2.. 2020 Wie Sie wissen, verläuft jede Entwicklung vom Primitiven über Kmpiz hin zum Einfachen. Wir werden sehe n… - Die Zeit trifft das Urteil (Tempus ferit iudicum).Sie benötigen in Englisch-Wörterbuch zur Kontrolle? https://translate.google.at/#en/de/When%20I%20open%20my%20linen%20closet%20this%20morning oder bevorzugen Sie den Google translator ((https://translate.google.at/#view=home&op=translate&sl=en&tl=de&text=german)? Februar 2020 28. 2. 2020; amel.de; Erhöhtes Risiko für Coronavirus-Infektion bei MS? https://www.amsel.de/multiple-sklerose-news/medizin/erhoehtes-risiko-fuer-coronavirus-infektion-bei-ms/ 28. 2. 2020; MSNT; #ACTRIMS2020 – Pregnancies and Menopause Affect Age of Progressive MS Onset https://multiplesclerosisnewstoday.com/news-posts/2020/02/20/actrims2020-session-1-nulliparity-or-early- menopause-are-associated-with-earlier-evolution-of-progressive-multiple-sclerosis-in-women 28. 2. 2020; amsel.de; Erhöhtes Risiko für Coronavirus-Infektion bei MS? https://www.amsel.de/multiple-sklerose-news/medizin/erhoehtes-risiko-fuer-coronavirus-infektion-bei-ms/ 28. 2. 2020; MSNT; #ACTRIMS2020 – Early Trial Data Support CNM-Au8 Improving Vision, Physical Abilities https://multiplesclerosisnewstoday.com/news-posts/2020/02/27/actrims2020-better-visual-acuity-physical-ability- evident-early-trial-data-cmn-au8-rrms 27. 2. 2020; DMSG; EXPERTENINTERVIEW: WIE GEFÄHRLICH IST DAS CORONAVIRUS FÜR MULTIPLE SKLEROSE - ERKRANKTE? https://www.dmsg.de/multiple-sklerose-news/dmsg-aktuell/news-article/News/detail/experteninterview-wie- gefaehrlich-ist-das-coronavirus-fuer-multiple-sklerose- erkrankte/?no_cache=1&cHash=d821455dac3810f9f442cbfa90c9c464 27. 2. 2020; DMSG; DAS CORONAVIRUS UND MULTIPLE SKLEROSE (MS) - WAS SIE WISSEN MÜSSEN https://www.dmsg.de/multiple-sklerose-news/dmsg-aktuell/news-article/News/detail/das-coronavirus-und-multiple- sklerose-ms-was-sie-wissen-muessen/?no_cache=1&cHash=b0f2386698678d41f9229d6c650d298b 25. 2. 2020; MSNT; Stopping Tysabri Early Tied to Active PPMS, Smoking and Depression in Patients, Study Finds https://multiplesclerosisnewstoday.com/news-posts/2020/02/19/duration-of-natalizumab-therapy-and-reasons-for- discontinuation-in-a-multiple-sclerosis-population 25. 2. 2020; MSNT; Potential Therapy, Anavex 2-73, Shows Ability to Protect Neurons and Promote Myelin in Early Tests https://multiplesclerosisnewstoday.com/news-posts/2020/02/24/anavex-life-sciences-announces-publication-of- foundational-data-for-anavex2-73-blarcamesine-in-multiple-sclerosis-ms 25. 2. 2020; MSNT; Age, Gender, Blood Glucose Affect Immune Cells’ Response to Tecfidera in RRMS Patients, Study Reports https://multiplesclerosisnewstoday.com/news-posts/2020/02/13/patient-specific-factors-modulate-leukocyte-response- in-dimethyl-fumarate-treated-ms-patients 25. 2. 2020; PubMed.gov; The influence of age at disease onset on future relapses and disability progression in multiple sclerosis patients on immunomodulatory treatment. https://www.ncbi.nlm.nih.gov/pubmed/32097512# 25. 2. 2020; PubMed.gov; Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort. https://www.ncbi.nlm.nih.gov/pubmed/32097470 22. 2. 2020; PubMed.gov; Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis. https://www.ncbi.nlm.nih.gov/pubmed/32097613 24. 2. 2020; MSNT; Masitinib Slows Disability Progression in PPMS and Non-active SPMS, Phase 2/3 Trial Reports https://multiplesclerosisnewstoday.com/news-posts/2020/02/21/ab-science-announces-positive-top-line-phase-2b3- results-for-oral-masitinib-in-progressive-forms-of-multiple-sclerosis 24. 2. 2020; PubMed.gov; Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. https://www.ncbi.nlm.nih.gov/pubmed/32088654 24. 2. 2020; MSNT; MS News that Caught My Eye Last Week: New Baclofen Pump, Bone Marrow Transplant Study, Bladder Problems and Life Quality, Urinary Diversion Surgery https://multiplesclerosisnewstoday.com/columns/2020/02/21/bone-marrow-transplant-baclofen-pump-urinary- diversion-surgery-quality-life 24. 2. 2020; MSNT; MS Patients Switching from Tysabri to Other Therapies May Risk Disease Activity https://multiplesclerosisnewstoday.com/news-posts/2020/02/24/ms-patients-switching-from-tysabri-may-risk-disease- activity-study-says 24. 2. 2020; MSNT; Masitinib Slows Disability Progression in PPMS and Non-active SPMS, Phase 2/3 Trial Reports https://multiplesclerosisnewstoday.com/news-posts/2020/02/21/ab-science-announces-positive-top-line-phase-2b3- results-for-oral-masitinib-in-progressive-forms-of-multiple-sclerosis 24. 2. 2020; PubMed.gov; Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. https://www.ncbi.nlm.nih.gov/pubmed/32088654 24. 2. 2020; MSNT; Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen https://multiplesclerosisnewstoday.com/news-posts/2020/02/19/flowonix-receives-fda-approval-to-market-prometra-ii- pump-for-use-with-intrathecal-baclofen 24. 2. 2020; MSNT; Bone Marrow Transplant Can Replace Overactive Immune Cells, Preventing Inflammation in MS, Study Says https://multiplesclerosisnewstoday.com/news-posts/2020/02/20/bone-marrow-transplant-can-replace-overactive- immune-cells-ms-preventing-inflammation 24. 2. 2020; MSNT; MS News that Caught My Eye Last Week: New Baclofen Pump, Bone Marrow Transplant Study, Bladder Problems and Life Quality, Urinary Diversion Surgery https://multiplesclerosisnewstoday.com/columns/2020/02/21/bone-marrow-transplant-baclofen-pump-urinary- diversion-surgery-quality-life 24. 2. 2020; MSNT; MS Patients Switching from Tysabri to Other Therapies May Risk Disease Activity https://multiplesclerosisnewstoday.com/news-posts/2020/02/24/ms-patients-switching-from-tysabri-may-risk- disease-activity-study-says 24. 2. 2020; MSNT; Masitinib Slows Disability Progression in PPMS and Non-active SPMS, Phase 2/3 Trial Reports https://multiplesclerosisnewstoday.com/news-posts/2020/02/21/ab-science-announces-positive-top-line-phase- 2b3-results-for-oral-masitinib-in-progressive-forms-of-multiple-sclerosis 24. 2. 2020; PubMed.gov; Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. https://www.ncbi.nlm.nih.gov/pubmed/32088654 24. 2. 2020; MSNT; Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen https://multiplesclerosisnewstoday.com/news-posts/2020/02/19/flowonix-receives-fda-approval-to-market- prometra-ii-pump-for-use-with-intrathecal-baclofen 24. 2. 2020; MSNT; Bone Marrow Transplant Can Replace Overactive Immune Cells, Preventing Inflammation in MS, Study Says https://multiplesclerosisnewstoday.com/news-posts/2020/02/20/bone-marrow-transplant-can-replace- overactive-immune-cells-ms-preventing-inflammation 24. 2. 2020; MSNT; Masitinib Slows Disability Progression in PPMS and Non-active SPMS, Phase 2/3 Trial Reports https://multiplesclerosisnewstoday.com/news-posts/2020/02/21/ab-science-announces-positive-top-line-phase-2b3- results-for-oral-masitinib-in-progressive-forms-of-multiple-sclerosis 24. 2. 2020; PubMed.gov; Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. https://www.ncbi.nlm.nih.gov/pubmed/32088654 21. 2. 2020; MSNT; Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen https://multiplesclerosisnewstoday.com/news-posts/2020/02/19/flowonix-receives-fda-approval-to-market-prometra-ii- pump-for-use-with-intrathecal-baclofen 21. 2. 2020; MSNT; Myeliviz Brings Hope for Faster MS Diagnosis https://multiplesclerosisnewstoday.com/columns/2020/02/18/myeliviz-brings-hope-for-faster-ms-diagnosis-and-better- tracking 21. 2. 2020; amssl.de; 233 Genvariationen für MS entdeckt https://www.amsel.de/multiple-sklerose-news/medizin/233-genvariationen-fuer-ms-entdeckt/ 21. 2. 2020; ms-uk; Peginterferon beta-1a recommended by NICE on NHS https://www.ms-uk.org/peginterferon-beta-1a-recommended-nice-nhs 20. 2. 2020; MSNT; Bone Marrow Transplant Can Replace Overactive Immune Cells, Preventing Inflammation in MS, Study Says https://multiplesclerosisnewstoday.com/news-posts/2020/02/20/bone-marrow-transplant-can-replace-overactive- immune-cells-ms-preventing-inflammation 20. 2. 2020; MSNT, #ACTRIMS2020 – Keynote Speaker Peter Cal abresi to Discuss Link Between Genetics and MS Severity https://multiplesclerosisnewstoday.com/news-posts/2020/02/18/new-research-links-genetics-and-ms-severity-offers- innovative-treatment-ideas-to-combat-ms-and-other-neurodegenerative-diseases 19. 2. 2020; ms-uk; Funding for new research into MS treatment https://www.ms-uk.org/funding-new-research-ms-treatment 17. 2. 2020; MSNT; Urinary Diversion Surgery May Be Used as Last Resort for Treating Urological Dysfunction in MS Patients, Study Showshttps://multiplesclerosisnewstoday.com/news-posts/2020/01/23 17. 2. 2020; MSNT; Ocrevus Use Rises Among New Starters with RRMS, Loses Ground to Other Therapies in PPMS https://multiplesclerosisnewstoday.com/ocrevus-use-increases-new-rrms-patients-drops-ppms-patients-genentech 15 . 2. 2020; PubMed.gov; Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association? https://www.ncbi.nlm.nih.gov/pubmed/32088655 15. 2. 2020; PubMed.gov; Demyelinating Diseases of the CNS (Brain and Spine). https://www.ncbi.nlm.nih.gov/pubmed/32119239 14. 2. 2020; MSNT; Smoking and MS: Not a Good Match https://multiplesclerosisnewstoday.com/columns/2020/02/11/70825 14. 2. 2020; MSNT; A Detailed Description of What to Expect During an MRI Scan https://multiplesclerosisnewstoday.com/disabled-to-enabled-a-column-by-jessie-ace/2020/02/13/what-to-expect-from- an-mri-scanner 14. 2. 2020; amsel.de; Aktiver Verlauf der Multiplen Sklerose https://www.amsel.de/multiple-sklerose-news/medizin/aktiver-verlauf-der-multiplen-sklerose/ 14. 2. 2020; ms-uk; Feeding tube before 50 can extend life https://www.ms-uk.org/feeding-tube-50-can-extend-life 13. 2. 2020; ms-uk; Cognitive decline in MS may not be progressive or inevitable https://www.ms-uk.org/cognitive-decline-ms-may-not-be-progressive-or-inevitable 13. 2. 2020; MSNT; Gold Nanocrystals in Phase 2 Testing Show ‘Robust’ Remyelination Potential in Animal Models https://multiplesclerosisnewstoday.com/news-posts/2020/02/11/clene-nanomedicine-publishes-results-demonstrating- preclinical-efficacy-of-cnm-au8-gold-nanocrystals-for-remyelination-in-multiple-sclerosis-in-scientific-reports 12. 2. 2020; ms-uk; Eating less meat and eggs may slow onset and progression of MS https://www.m s-uk.org/eating-less-meat-and-eggs-may-slow-onset-and-progression-ms 11. 2. 2020; PubMed.gov; Restless legs syndrome among multiple sclerosis patients in Lebanon. https://www.ncbi.nlm.nih.gov/pubmed/32113183 11. 2. 2020; .emed-ms.de; Video: Neurobiologie der Gliazellen anschaulich erklärt http://www.emed-ms.de/index.php?id=533&tt_news=3219 11. 2. 2020; MSNT; Cognitive Decline in MS May Not Be Inevitable or Progressive, 10-year Study Suggests https://multiplesclerosisnewstoday.com/news-posts/2020/02/05/a-longitudinal-study-of-cognitive-function-in-multiple-sclerosis-is- decline-inevitable 11. 2. 2020;MSNT; Inflammasome Pathway Linked to MS and Diseases of Aging Has an ‘Off’ Switch, Early Study https://multiplesclerosisnewstoday.com/news-posts/2020/02/07/molecular-switch-reverses-chronic-inflammation-and-aging 11. 2. 2020; MSNT; Ethnic Differences in MS Evident in Antibody-secreting Cells in Blood, US Study Suggests https://multiplesclerosisnewstoday.com/news-posts/2020/02/03/black-african-and-latinoa-identity-correlates-with-increased- plasmablasts-in-ms 10. 2. 2020; amsel.de; Studien sollen sich stärker am MS-Patienten orientieren https://www.amsel.de/multiple-sklerose-news/medizin/studien-sollen-sich-staerker-am-ms-patienten-orientieren/ 10. 2. 2020; idw; CLINSPECT-M: Klinisches Massenspektrometrie-Zentrum für molekulare Hirnforschung in Mü https://idw-online.de/de/news731258 10. 2. 2020; MSIF; Fighting the myths of MS and motherhood https://www.msif.org/news/2020/02/06/fighting-the-myths-of-ms-and-motherhood/ 10. 2. 2020; MSIF; ‘Stronger together’ – MS organisations from Latin America reunite https://www.msif.org/news/2020/02/06/stronger-together-ms-organisations-from-latin-america-reunite/ 6. 2. 2020; MSIF; Access to MS drugs is a problem worldwide, in rich and poor countries alike https://www.msif.org/news/2020/02/06/access-to-ms-drugs-is-a-problem-worldwide-in-rich-and-poor-countries-alike/ 7. 2. 2020; ms-uk; 85% of people with MS experience insomnia https://www.ms-uk.org/85-people-ms-experience-insomnia 7. 2. 2020; idw; Video: Neurobiologie der Gliazellen anschaulich erklärt https://idw-online.de/de/news731187 7. 2. 2020; ms-uk; New trial will compare HSCT to other MS treatment https://www.ms-uk.org/new-trial-will-compare-hsct-other-ms-treatment 7. 2. 2020; MSIF; Fighting the myths of MS and motherhood https://www.msif.org/news/2020/02/06/fighting-the-myths-of-ms-and-motherhood/ 7. 2. 2020; MSNT; Fewer New Brain Lesions Seen in Patients Treated with BTK Blocker in Phase 2 Trial, Results Show https://multiplesclerosisnewstoday.com/news-posts/2020/02/06/sanofi-brain-penetrant-btk-inhibitor- meets-primary-endpoint- of-phase-2-trial-in-relapsing-multiple-sclerosis 7. 2. 2020; MSNT; Fewer New Brain Lesions Seen in Patients Treated with BTK Blocker in Phase 2 Trial, Results Show https://multiplesclerosisnewstoday.com/news-posts/2020/02/06/sanofi-brain-penetrant-btk-inhibitor-meets-primary-endpoint-of- phase-2-trial-in-relapsing-multiple-sclerosis 6, 2. 2020; ms-uk; Comorbidities do not raise risk of MS-related hospitalisation https://www.ms-uk.org/comorbidities-do-not-raise-risk-ms-related-hospitalisation 6, 2. 2020; MSNT; Could Myeliviz, a New Imaging Agent of Myelin, Be a Game-changer? https://multiplesclerosisnewstoday.com/silver-linings-a-column-by-jennifer-powell/2020/02/03/myeliviz-myelin-imaging-agent- clinical-trial-fda-demyelination 6, 2. 2020; MSNT; Interleukin-17A Plays Key Role in Inflammation in MS, Mouse Study Finds https://multiplesclerosisnewstoday.com/news-posts/2020/02/04/new-discovery-provides-hope-for-improved-multiple-sclerosis- therapies 6, 2. 2020 ; ms-uk; Comorbidities do not raise risk of MS-related hospitalisation https://www.ms-uk.org/comorbidities-do-not-raise-risk-ms-related-hospitalisation 6, 2. 2020; MSNT; Could Myeliviz, a New Imaging Agent of Myelin, Be a Game-changer? https://multiplesclerosisnewstoday.com/silver-linings-a-column-by-jennifer-powell/2020/02/03/myeliviz-myelin-imaging-agent- clinical-trial-fda-demyelination 6, 2. 2020; MSNT; Interleukin-17A Plays Key Role in Inflammation in MS, Mouse Study Finds https://multiplesclerosisnewstoday.com/news-posts/2020/02/04/new-discovery-provides-hope-for-improved-multiple-sclerosis- therapies 5. 2. 2020; MSNT; QyScore, Imaging Software that Analyzes MRI Markers https://multiplesclerosisnewstoday.com/news-posts/2020/02/03/qynapse-receives-fda-clearance-for-qyscore-a-novel-imaging- software-for-central-nervous-system-diseases 5. 2. 2020; MSNT; Having Other Health Conditions Does Not Raise Risk of MS-related Hospitalization, Study Finds https://multiplesclerosisnewstoday.com/news-posts/2020/01/31/impact-of-comorbidity-on-hospitalizations-in-individuals-newly- diagnosed-with-multiple-sclerosis-a-longitudinal-population-based-study 4. 2. 2020; ms-uk; Newly observed immune cell interaction may lead to more therapies for MS https://www.ms-uk.org/newly-observed-immune-cell-interaction-may-lead-more-therapies-ms 4. 2. 2020;MSIF; Discovering life-changing treatments for progressive MS https://www.msif.org/news/2020/02/03/discovering-life-changing-treatments-for-progressive-ms/ 4. 2. 2020; MSNT; 5 Hacks to Help Manage Your Fatigue https://multiplesclerosisnewstoday.com/disabled-to-enabled-a-column-by-jessie-ace/2020/01/30/fatigue-energy-tips-delegating- tasks 4. 2. 2020; MSNT; Mesenchymal Stem Cell Transplant Safe and Helps Delay MS Progression, Analysis Shows https://multiplesclerosisnewstoday.com/news-posts/2020/01/30/autologous-mesenchymal-stem-cell-transplantation-in-multiple- sclerosis-a-meta-analysis 4. 2. 2020; MSNT; Cerebrospinal Fluid of MS Patients More Diverse and Filled with Pro-Inflammatory Cells, Study Showshttps://multiplesclerosisnewstoday.com/news-posts/2020/01/17/integrated-single-cell-analysis-of-blood-and-cerebrospinal- fluid-leukocytes-in-multiple-sclerosis 3. 2. 2020; amsrel.de; Studie bestätigt Fehlgeburtenrisiko unter Modafinil https://www.amsel.de/multipele-sklerose-news/medizin/studie-bestaetigt-fehlgeburtenrisiko-unter-modafinil/ 1.2.2020; MSNT; What can changes in grey matter mean for MS? https://multiplesclerosisnewstoday.com/sponsored-content/2020/02/01/what-can-changes-in-grey-matter-mean-for-ms-sponsored- postp Glücklich, wer mit den Verhältnissen zu brechen versteht, ehe sie ihn gebrochen haben! Franz von Liszt zur Startseite
MS-News, Infos und Links